lilly tirzepatide Compounders lose battle over Eli weight loss drug and FDA shortage list Lilly escalates compounding challenge after

When Dr Cecil was on a GLP-1 using her previous insurance, she said she wouldn't allow herself to lose as much weight as she wanted to avoid crossing the BMI threshold

Right now, that looks premature

Additionally, it suppresses glucagon secretion , a hormone that raises blood glucose, and slows gastric emptying , which helps moderate post-meal blood sugar spikes

However, starting from January 1, 2025, Blue Cross Blue Shield Michigan will no longer cover any GLP-1 weight loss drugs, including Zepbound, Saxenda, and Wegovy, for fully insured large group commercial members

These plans may also have specific rules like prior authorization or limits on how many medications you can get

We analyze customer reviews, read complaint and comments, and talk to medical professionals to get their opinions on weight loss subscriptions